A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy

BACKGROUND: The prevalence of esophageal stenosis caused by immune checkpoint inhibitors in the context of induced immune mucositis and esophagitis is extremely rare. CASE PRESENTATION: We report the case of a patient with stage IV pulmonary adenocarcinoma treated for 6 months with nivolumab who dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Horisberger, Alice, La Rosa, Stefano, Zurcher, Jean-Philippe, Zimmermann, Stefan, Spertini, Francois, Coukos, George, Obeid, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307169/
https://www.ncbi.nlm.nih.gov/pubmed/30587227
http://dx.doi.org/10.1186/s40425-018-0481-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307169/
https://www.ncbi.nlm.nih.gov/pubmed/30587227
http://dx.doi.org/10.1186/s40425-018-0481-0

Ejemplares similares